Switching From Prasugrel to Clopidogrel: Navigating in Unknown Waters

JACC: Cardiovascular Interventions

Volumn 6, Issue 2, 2013, Pages 166-168

  Angiolillo, Dominick J ^a   Rollini, Fabiana ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

P2Y12 receptor antagonist; platelet reactivity; switch

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; PIPERAZINE DERIVATIVE; PRASUGREL; PURINERGIC P2Y RECEPTOR ANTAGONIST; THIOPHENE DERIVATIVE; TICLOPIDINE;

ACUTE CORONARY SYNDROME; DRUG EFFECT; DRUG SUBSTITUTION; FEMALE; HUMAN; MALE; NOTE; THROMBOCYTE;

ACUTE CORONARY SYNDROME; BLOOD PLATELETS; DRUG SUBSTITUTION; FEMALE; HUMANS; MALE; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; THIOPHENES; TICLOPIDINE;

EID: 84881293804     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2012.12.001     Document Type: Editorial

References (9)

1. Angiolillo, D.J., The evolution of antiplatelet therapy in the treatment of acute coronary syndromes: from aspirin to the present day. Drugs 72 (2012), 2087–2116.
2. Angiolillo, D.J., Fernandez-Ortiz, A., Bernardo, E., et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol 49 (2007), 1505–1516.
3. Bonello, L., Tantry, U.S., Marcucci, R., et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 56 (2010), 919–933.
4. Rollini, F., Tello-Montoliu, A., Angiolillo, D.J., Advances in platelet function testing assessing bleeding complications in patients with coronary artery disease. Platelets 23 (2012), 537–551.
5. Angiolillo, D.J., Ferreiro, J.L., Platelet and genetic testing for clopidogrel hyporesponsiveness perspective: use as a research tool. J Am Coll Cardiol, 2013 In press.
6. Ferreiro, J.L., Angiolillo, D.J., New directions in antiplatelet therapy. Circ Cardiovasc Interv 5 (2012), 433–445.
7. Azmoon, S., Angiolillo, D.J., Switching antiplatelet regimens: alternatives to clopidogrel in patients with acute coronary syndrome undergoing PCI: a review of the literature and practical considerations for the interventional cardiologist. Catheter Cardiovasc Interv, 2012 May 14, 10.1002/ccd.24480 [Epub ahead of print].
8. Kerneis, M., Silvain, J., Abtan, J., et al. Switching acute coronary syndrome patients from prasugrel to clopidogrel. J Am Coll Cardiol Intv 6 (2013), 158–165.
9. Antman, E.M., Wiviott, S.D., Murphy, S.A., et al. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis. J Am Coll Cardiol 51 (2008), 2028–2033.